Clinical Trial Update: Safety, Reactogenicity and Immunogenicity of Heat-stable Rotavirus Vaccine (HSRV) in Adults and Infants [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial update reporting on the safety, reactogenicity, and immunogenicity of the Heat-stable Rotavirus Vaccine (HSRV) in adults and infants fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Gastroenteritis

Drugs mentioned

• Heat-stable Rotavirus Vaccine (HSRV)

Snippet

Sponsor: MSD Wellcome Trust Hilleman Laboratories Pvt. Ltd. | Conditions: Rotavirus Gastroenteritis | Phase 1, Phase 2 | Status: COMPLETED